The current PE ratio of MLAB cannot be calculated, as the latest EPS of -$45.61 is negative. Mesa Laboratories's last PE ratio on record was 616.29 in December 2023.
The mean historical PE ratio of Mesa Laboratories over the last ten years is 213.55. Looking back at the last ten years, MLAB's PE ratio peaked in the Mar 2023 quarter at 1,027.82, with a price of $174.73 and an EPS of $0.17. The Dec 2014 quarter marked the lowest point at 25.1, with a price of $77.31 and an EPS of $3.08.
Maximum annual increase: 355.38% in 2020
Maximum annual decrease: -31.46% in 2021
Year | PE ratio | Change |
---|---|---|
2024 | N/A | N/A |
2023 | 1,027.82 | 45.17% |
2022 | 708 | 91.9% |
2021 | 368.94 | -31.46% |
2020 | 538.31 | 355.38% |
2019 | 118.21 | N/A |
2018 | N/A | N/A |
2017 | 40.36 | 29.86% |
2016 | 31.08 | 17.11% |
2015 | 26.54 | -23.25% |
Stock name | PE ratio | Market cap |
---|---|---|
MMM 3M Co | 16.42 | $70.99B |
BRKR Bruker Corp | 28 | $8.83B |
GE General Electric Co | 29.88 | $185.6B |
AME Ametek Inc | 31.9 | $42.57B |
TMO Thermo Fisher Scientific Inc | 33.08 | $202.33B |
DHR Danaher Corp | 43.62 | $166.66B |
STE STERIS plc | 47.43 | $20.6B |
HBIO Harvard Bioscience Inc | N/A | $90.72M |
RMTI Rockwell Medical Inc | N/A | $69.49M |
ANGO Angiodynamics Inc | N/A | $353.11M |
MLAB Mesa Laboratories Inc | N/A | $712.87M |
The current price to earnings ratio of MLAB cannot be determined, as its EPS of -$45.61 is negative.
The 3-year average price to earnings ratio for MLAB stock is 589.76.
The 5-year average price to earnings ratio for MLAB stock is 468.8.
Over the last ten years, the Mar 2023 quarter recorded the highest quarterly PE ratio at 1,027.82.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.